AKT1 and diabetes mellitus: In summary, our study demonstrates that GEE lowers blood glucose and relieves the clinical signs of diabetes in mice, likely mediated through greater glucose uptake in peripheral tissues through the upregulation of GLUT4 and the PI3K/Akt pathway.